JW is a patient with T2D. His current A1C is 7.7% despite treatment with metformin ER 1000 mg twice daily. JW does not have a history of ASCVD, HF, or CKD, and is not considered high risk for these comorbidities. In the absence of these compelling indications, all of the following are recommended as key considerations by the ADA when selecting an add-on glucose-lowering agent to lower A1C, EXCEPT: A. The need to minimize hypoglycemia B. Glucose-lowering efficacy C. Efficacy for weight loss D. The manufacturer of the product
[Expert Solution]: JW is a patient with T2D
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.